BrainsWay’s Deep Transcranial Magnetic Stimulation (Deep TMS™) therapy has demonstrated exceptional efficacy in rigorous clinical studies, offering hope and healing for patients with treatment-resistant mental health conditions.
Response Rate in Real-World Settings
Remission Rate for Depression
Patients in Clinical Studies
All studies are based on meticulous, evidence-based analysis published in prestigious medical journals, utilizing double-blind, randomized control trials (RCT) and multicentre patient arms to ensure maximum objectivity.
Regulatory approval for safety and efficacy
Published in top medical journals
Studies across multiple institutions
Rigorous randomized control trials
Clinical data from over 1,300 patients in real practice settings who completed at least 30 sessions showed remarkable outcomes.
Achieved Response
Achieved Remission
Response and remission rates measured across different clinical assessment scales
Six-week Deep TMS treatment course showed significant clinical improvement of OCD symptoms, with results comparable to 12-week pharmacotherapy.
Analysis of over 200 OCD patients in clinical practice settings receiving 29 treatment sessions.
Achieved Response
(30%+ symptom reduction on Y-BOCS scale)
Progressive improvement in OCD symptoms measured by CGI-I scale across treatment weeks, showing sustained benefits for patients unresponsive to SSRIs or psychotherapy
Of participants experienced reduced MDD symptoms
Studies suggest that TMS conducted during or in proximity to psychotherapy can increase the efficacy of both treatments’ combined effect, offering patients multiple pathways to recovery.
With increasing studies solidifying Deep TMS therapy’s high level of efficacy, more individuals are finding hope and healing through this innovative treatment.
Explore more about TMS treatment and our services
